Ahead of U.N. MDG Summit, media outlets examine various aspects of goals
Ahead of the U.N. Millennium Development Goals (MDGs) Summit on September 20-22, the media examines different aspects of the MDGs. Continuer la lecture
Ahead of the U.N. Millennium Development Goals (MDGs) Summit on September 20-22, the media examines different aspects of the MDGs. Continuer la lecture
Plaque-causing bacteria can jailbreak from the mouth into the bloodstream and increase your risk of heart attack says a scientist at the Society for General Microbiology’s autumn meeting in Nottingham. Continuer la lecture
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier’s Global Malaria Resource, http://www.malarianexus.com. Continuer la lecture
A new study by researchers from the London School of Hygiene and Tropical Medicine, Cambridge University and the Karolinska Institute in Sweden has found that even light or moderate intensity physical activity, such as walking or cycling, can substantially reduced the risk of early death. Continuer la lecture
BioVigil LLC has released the second generation of the BioVigil hand hygiene monitoring system. The innovative system enables hospitals to more effectively combat Hospital-Acquired Infections (HAIs) by dramatically increasing hand hygiene compliance among healthcare workers. Continuer la lecture
Employers nationwide are recognizing that the federal government intends to expand and strengthen Occupational Safety and Health Administration (OSHA) authority, and ensure strict adherence to industry-specific guidelines. National claims and risk management service provider Avizent is preparing for these changes by expanding its in-house Loss Control program to serve clients nationwide. Continuer la lecture
Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company’s Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be conducted by New York State Psychiatric Institute researchers. Continuer la lecture